The truth is PBMs want the same thing their clients and consumers want: lower, not higher drug prices. That’s why PBMs promote generics over brands whenever possible. The large, sophisticated purchasers who hire PBMs—Fortune 500 companies, major labor unions, and plans in government programs like Medicare Part D—offer performance incentives to reduce overall pharmacy costs.
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
In a recent article at BenefitsPRO, Dan Cook talks about the movement to have employers “rise up and fight their own battles with the drug
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have
